Stay updated on Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new site revision tag (v3.5.3) was added. Related topics such as Prostate cancer, MedlinePlus Genetics, and Revision: v3.5.2 were removed, indicating a minor navigation/content cleanup.
    Difference
    0.2%
    Check dated 2026-04-30T17:15:37.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added “Prostate cancer” related topics, including MedlinePlus Genetics, as reference links on the page.
    Difference
    0.2%
    Check dated 2026-04-23T15:21:20.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added. Prostate cancer and the related topic MedlinePlus Genetics were removed, and Revision: v3.5.0 was removed.
    Difference
    0.2%
    Check dated 2026-04-16T11:08:37.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added related topics to the study record: Prostate cancer and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-04-09T08:30:01.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; the previous revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:12:16.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and v3.4.2 removed, indicating a minor page version update.
    Difference
    0.1%
    Check dated 2026-03-11T17:24:40.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.